Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 432)
Posted On: 06/09/2022 12:51:38 PM
Post# of 154874
Posted By: seemingly-harmless
Re: MGK_2 #124388
aplaviroc and vicriviroc - new to me

wikipedia

aplaviroc - GSK - all studies of aplaviroc were discontinued due to liver toxicity

vicriviroc - Merck - decided to not pursue regulatory approval for use in treatment-experienced patients because the drug did not meet primary efficacy endpoints in late stage trials. Clinical trials continue in patients previously untreated for HIV

and of course
maraviroc - can cause serious, life-threatening side effects. These include liver problems, skin reactions, and allergic reactions. An allergic reaction may happen before liver problems occur. Official labeling of Selzentry has BLACK BOX warning for hepatotoxicity. (although) The MOTIVATE trials showed no clinically relevant differences in safety between the maraviroc and placebo groups. CCR5 drugs may facilitate the emergence of resistant strains of HIV-1.... maraviroc-resistant variants of HIV-1 have already been generated in vitro by mutating residues in the V3 loop of gp120

leronlimab looking good in this group













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site